메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Ansell Receives Frost & Sullivan's 2025 Global Sustainable Hospital Supplies Company of the Year Award

[ 메디채널 김갑성 기자 ] Ansell is recognised for its leadership in hospital supply sustainability, visionary innovation, and customer impact on a global scale. SAN ANTONIO, Aug. 18, 2025 -- Frost & Sullivan, a leader in the information and growth advisory industry, has awarded the title of "2025 Global Sustainable Hospital Supplies Company of the Year" to Ansell, a global provider of safety solutions. Recognised for its outstanding achievements in innovation and customer impact, Ansell is focused on driving sustainable innovation by using fewer or safer materials and continuous
- 김갑성 기자
- 2025-08-18 22:00
Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform

[ 메디채널 김갑성 기자 ] Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost adherence, retention and deliver breakthrough health outcomes with cost savings DUBLIN, Aug. 18, 2025 -- Aon plc (NYSE: AON), a leading global professional services firm, today announced a strategic investment in eMed Population Health, Inc., an emerging leader in the delivery of GLP-1 programs. The partnership will enhance employer sponsored access to GLP-1 therapies and scale solutions for obesity. The investment follows the launch earlier this year of Aon's
- 김갑성 기자
- 2025-08-18 21:30
Datasea Achieves Breakthrough in Acoustic Technology, Accelerating Billion-Dollar Commercialization in Healthcare

DTSS' Acoustic innovation Addresses the Healthcare Application Market Projected to Exceed $100 Billion in China and Approach $90 Billion Globally by 2030 BEIJING, Aug. 18, 2025 -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology enterprise specializing in advanced acoustic high-tech products and AI multimodal digital solutions, today announced a milestone breakthrough in its acoustic technology. The Company has successfully achieved an exciting leap forward in its acoustic core technologies with the integration of sound wa
- 김갑성 기자
- 2025-08-18 21:30
Asia Pacific View: A Window to Understanding China--Beijing

BEIJING, Aug. 18, 2025 -- A Window to Understanding China—Beijing is a short animated film series bringing Beijing's story to life. Using lighthearted expression and humorous language, it showcases the city's dynamic evolution in the modern era across multiple dimensions, including historical and heritage, cultural fusion, culinary delights, sci-tech innovation, artistic creativity, and urban renewal. Beijing boasts a long and profound history. From the Yan State during the Zhou Dynasty (1046-256 BC) to its role as the capital of five successive dynasties—the
- 김장윤(JASON KIM) 기자
- 2025-08-18 21:24
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).

[ 메디채널 김갑성 기자 ] This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taking the lead in business development, with several companies in the due diligence stage, and additional deals are anticipated. SEOUL, South Korea, Aug. 18, 2025 -- Avixgen, a subsidiary of Dx&Vx, announced on the 18th that it has signed a licensing-out agreement worth approximately USD 360 million with a U.S. biotechnology company for its next-generation drug delivery platform, ACP (Advanced Cell Penetrating Pep
- 김갑성 기자
- 2025-08-18 21:00
NYSE Content Advisory: Pre-Market Update + 'Taking Stock' Series launches before Closing Bell

NEW YORK, Aug. 18, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + ‘Taking Stock’ Series launches before Closing Bell Ashley Mastronardi delivers the pre-market update on August 18th Stocks are fractionally lower following another winning week for the major averages. The DOW rose by 1.7% while the S&P 500 finished higher for the fourth time in the past five week
- 황정호 기자
- 2025-08-18 20:55
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, Aug. 18, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal Letter"), dated August 18, 2025, from Oceanpine Investment Fund II LP and Oceanpine Capital Inc. (collectively, "Oceanpine
- 황정호 기자
- 2025-08-18 20:00
XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025

CAMBRIDGE, Mass., Aug. 18, 2025 -- XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced that it will report its interim results for the six months ended June 30, 2025 on Wednesday, August 27, 2025, after the Hong Kong market closes. The Company will hold a conference call in Chinese with English simultaneous interpretation at 7:00 PM Hong Kong/Beijing Time on August 27, 2025 (7:00 AM U.S. Eastern
- 황정호 기자
- 2025-08-18 18:59
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS

Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportion Research and development expenses was approximately RMB611.5 million Loss for the period was RMB145.2 million; adjusted loss for the period[1] was RMB69.4 million Cash and cash equivalents[2] amounted to approximately RMB4527.8 million, reflecting ample cash reserves Note1: Calculated by deducting equity-settled share-based payment from loss for the year. Note2: Comprises cash and cash eq
- 김갑성 기자
- 2025-08-18 18:29
India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

NEW DELHI, Aug. 18, 2025 -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one of India's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across Delhi, Gurugram and Ghaziabad further reinforces its vision to be a destination for world-class cancer care, catering to patients across India as well as international geographies. Dr. Surender Dabas brings with him more than 22
- 김갑성 기자
- 2025-08-18 18:23

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2025-09-06_SAT

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 06일 06시 40분